Cargando…

Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States

Background. This retrospective study investigates the healthcare costs of herpes zoster (HZ) in patients with selected immune-compromised (IC) conditions in the United States (US). Methods. Patients with incident HZ diagnosis (index date) were selected from nationwide administrative claims databases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qian, Chen, Shih-Yin, Burstin, Stuart J., Levin, Myron J., Suaya, Jose A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943564/ https://www.ncbi.nlm.nih.gov/pubmed/27419151 http://dx.doi.org/10.1093/ofid/ofw067

Ejemplares similares

Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States
por: Suaya, Jose A., et al.
Publicado: (2014)

Incidence of herpes zoster in patients with altered immune function
por: Chen, S.-Y., et al.
Publicado: (2013)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed With COVID-19 in the United States
por: Bhavsar, Amit, et al.
Publicado: (2022)

Risk Factors for Herpes Zoster Among Adults
por: Marin, Mona, et al.
Publicado: (2016)

Trends in Hospitalizations With Primary Varicella and Herpes Zoster During the Prevaricella and Initial Postvaricella and Herpes Zoster Vaccine Eras, Connecticut, 1994–2012
por: Humes, Elizabeth A., et al.
Publicado: (2015)

Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster
por: Levinson, Rebecca T., et al.
Publicado: (2016)

A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia
por: Carpenter, Christopher F, et al.
Publicado: (2019)

Partner Bereavement and Risk of Herpes Zoster: Results from Two Population-Based Case-Control Studies in Denmark and the United Kingdom
por: Schmidt, Sigrun A. J., et al.
Publicado: (2017)

Herpes zoster complicated by phrenic nerve palsy and respiratory compromise
por: Apiyo, Paska, et al.
Publicado: (2019)

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
por: Cunningham, Anthony L, et al.
Publicado: (2018)

Vaccination against herpes zoster in developed countries: State of the evidence
por: Drolet, Mélanie, et al.
Publicado: (2013)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
por: Grupping, Katrijn, et al.
Publicado: (2017)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Cost-Effectiveness of Herpes Zoster Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2019)

The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy
por: Matthews, Sean, et al.
Publicado: (2019)

Text-Based Identification of Herpes Zoster Ophthalmicus With Ocular Involvement in the Electronic Health Record: A Population-Based Study
por: Zheng, Chengyi, et al.
Publicado: (2021)

Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009
por: Suaya, Jose A, et al.
Publicado: (2014)

Herpes zoster ophthalmicus or Herpes zoster maxillaris?
por: Chandravanshi, Shivcharan Lal, et al.
Publicado: (2009)

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

914. Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination in a United States Administrative Claims Database
por: Jain, Purva, et al.
Publicado: (2023)

Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis
por: Marra, Fawziah, et al.
Publicado: (2016)

Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database
por: Yoon, Jin Gu, et al.
Publicado: (2023)

Analytic Characterization of the Herpes Simplex Virus Type 2 Epidemic in the United States, 1950–2050
por: Ayoub, Houssein H, et al.
Publicado: (2021)

Burden of Herpes Zoster Among Patients with Psoriasis in the United States
por: Singer, David, et al.
Publicado: (2023)

Herpes Zoster
por: Warneros Loyo, María de Lourdes
Publicado: (1995)

Herpes Zoster
Publicado: (1890)

Herpes Zoster
por: Wile, Henry
Publicado: (1886)

Herpes Zoster and Sulphanilamide
por: Biswas, J. C.
Publicado: (1942)

Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines
por: Park, Seong Yeon, et al.
Publicado: (2022)

Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France
por: Blein, Cecile, et al.
Publicado: (2015)

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
por: Boutry, Céline, et al.
Publicado: (2021)

Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study
por: Ishiguro, Chieko, et al.
Publicado: (2023)

The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence
por: Tseng, Hung Fu, et al.
Publicado: (2020)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Annual incidence rates of herpes zoster among an immunocompetent population in the United States
por: Johnson, Barbara H., et al.
Publicado: (2015)

Herpes Zoster / Revisión Bibliográfica /
por: Escamilla Sánchez, Jacqueline
Publicado: (1993)

Inflammatory Bowel Disease and the Risk of Herpes Zoster
por: Lai, Shih-Wei
Publicado: (2019)

Effectiveness of herpes zoster vaccination in an older United Kingdom population
por: Walker, Jemma L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cbvfb7bdcauoua2sphg3ejkhj4